GP73 is down-regulated in gastric cancer and associated with tumor differentiation

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Chen, Le Gao ^a   Wang, Hui Ju ^a   Yao, Hai bo ^a   Guan, Tian Pei ^a   Wu, Fang ^a   He, Xu Jun ^a   Ma, Ying Yu ^a   Tao, Hou Quan ^a   Ye, Zai Yuan ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Gastric cancer; GP73; Tumor differentiation

Indexed keywords

CELL MEMBRANE PROTEIN; GOLGI PROTEIN 73; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; DOWN REGULATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STOMACH CANCER; STOMACH MUCOSA; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; HUMANS; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878661821     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-132     Document Type: Article

References (26)

1. Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, Koutoubi Z, Fimmel CJ. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 2000, 249:53-65. 10.1016/S0378-1119(00)00136-0, 10831838.
2. Kim HJ, Lv D, Peng T, Ma X, Zhang Y. Golgi phosphoprotein 2 in physiology and in diseases. Cell Biosci 2012, 2:31. 10.1186/2045-3701-2-31, 3448521, 22958594.
3. Puri S, Bachert C, Fimmel CJ, Linstedt AD. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 2002, 3:641-653. 10.1034/j.1600-0854.2002.30906.x, 12191016.
4. Wright LM, Yong S, Picken MM, Rockey D, Fimmel CJ. Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2). Int J ClinExp Pathol 2009, 2:34-47.
5. Zhou Y, Li L, Hu L, Peng T. Golgi phosphoprotein 2 (GP73/GP73/GOLM1) interacts with secretory clusterin. Mol Biol Rep 2011, 38:1457-1462. 10.1007/s11033-010-0251-7, 20842452.
6. Bachert C, Fimmel C, Linstedt AD. Endosomal trafficking and proproteinconvertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic 2007, 8:1415-1423. 10.1111/j.1600-0854.2007.00621.x, 17662025.
7. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 2002, 35:1431-1440. 10.1053/jhep.2002.32525, 12029628.
8. Kladney RD, Tollefson AE, Wold WS, Fimmel CJ. Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. Virology 2002, 301:236-246. 10.1006/viro.2002.1523, 12359426.
9. Hu JS, Wu DW, Liang S, Miao XY. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population. Med Oncol 2010, 27:339-345. 10.1007/s12032-009-9215-y, 19399652.
10. Sun Y, Yang H, Mao Y, Xu H, Zhang J, Li G, Lu X, Sang X, Zhao H, Zhong S, Huang J, Zhang H. Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival. J Gastroenterol Hepatol 2011, 26:1207-1212. 10.1111/j.1440-1746.2011.06733.x, 21443671.
11. Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien PA, Bahra M, Neuhaus P, Wild P, Fritzsche F, Moch H, Jochum W, Kristiansen G. Golgi phosphoprotein 2 (GP73) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology 2009, 49:1602-1609. 10.1002/hep.22843, 19291786.
12. Zhang F, Gu Y, Li X, Wang W, He J, Peng T. Up-regulated Golgi phosphoprotein 2 (GP73) expression in lung adenocarcinoma tissue. Clin Biochem 2010, 43:983-991. 10.1016/j.clinbiochem.2010.05.010, 20501332.
13. Kristiansen G, Fritzsche FR, Wassermann K, Jäger C, Tölls A, Lein M, Stephan C, Jung K, Pilarsky C, Dietel M, Moch H. GP73 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer 2008, 99:939-948. 10.1038/sj.bjc.6604614, 2538754, 18781151.
14. Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA, Granger J, Vellaichamy A, Sreekumar A, Yu J, Gu W, Shen R, Ghosh D, Wright LM, Kladney RD, Kuefer R, Rubin MA, Fimmel CJ, Chinnaiyan AM. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer. Neoplasia 2008, 10:1285-1294. 2570605, 18953438.
15. Fritzsche FR, Kristiansen G, Riener MO, Dietel M, Oelrich B. GOLPH2 expression may serve as diagnostic marker in seminomas. BMC Urol 2010, 10:4. 10.1186/1471-2490-10-4, 2843682, 20184749.
16. Fritzsche FR, Riener MO, Dietel M, Moch H, Jung K, Kristiansen G. GP73 expression in renal cell cancer. BMC Urol 2008, 8:15. 10.1186/1471-2490-8-15, 2614419, 19014428.
17. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 2005, 43:1007-1012. 10.1016/j.jhep.2005.05.028, 16137783.
18. Zhou Y, Yin X, Ying J, Zhang B. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis. BMC Cancer 2012, 12:17. 10.1186/1471-2407-12-17, 3292967, 22244200.
19. Ling Y. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006, 12:17-20.
20. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002, 94:2511-2516. 10.1002/cncr.10492, 12015777.
21. Ba MC, Long H, Tang YQ, Cui SZ. GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review. Int J Clin Exp Pathol 2012, 5:874-881. 3484483, 23119104.
22. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS, Dwek RA, Mattu TS, Mehta AS. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci USA 2005, 102:779-784. 10.1073/pnas.0408928102, 545516, 15642945.
23. Iftikhar R, Kladney RD, Havlioglu N, Schmitt-Gräff A, Gusmirovic I, Solomon H, Luxon BA, Bacon BR, Fimmel CJ. Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterol 2004, 99:1087-1095. 10.1111/j.1572-0241.2004.30572.x, 15180730.
24. Wright LM, Huster D, Lutsenko S, Wrba F, Ferenci P, Fimmel CJ. Hepatocyte GP73 expression in Wilson disease. J Hepatol 2009, 51:557-564. 10.1016/j.jhep.2009.05.029, 2750828, 19596473.
25. Li L, Wen L, Gong Y, Mei G, Liu J, Chen Y, Peng T. Xenopus as a model system for the study of GOLPH2/GP73 function: Xenopus GOLPH2 is required for pronephros development. PLoS One 2012, 7:e38939. 10.1371/journal.pone.0038939, 3375297, 22719994.
26. Moggs JG, Ashby J, Tinwell H, Lim FL, Moore DJ, Kimber I, Orphanides G. The need to decide if all estrogens are intrinsically similar. Environ Health Perspect 2004, 112:1137-1142. 10.1289/ehp.7028, 1247471, 15289156.